EPA approves continued use of controversial neonicotinoid insecticides, with added restrictions to protect bees

screen shot at am
Seeds coated with a neonicotinoid insecticide.

The EPA announced [Jan 30] it supports the continued use and registration of neonicotinoids, a class of insecticides linked to declines in bees, aquatic insects and birds.

The Environmental Protection Agency released its proposed interim decisions for acetamiprid, clothianidin, dinotefuran, imidacloprid, and thiamethoxam. Neonicotinoids are used on a wide variety of crops.

[Editor’s note: Read The world faces ‘pollinator collapse’? How and why the media get the science wrong time and again to learn more.]

The proposed interim decisions also contain new measures to reduce potential ecological risks, particularly to pollinators, and protect public health, according to the EPA.

Among the management measures being proposed are measures to “help keep pesticides on the intended target and reduce the amount used on crops associated with potential ecological risks,” the agency said.

The EPA is also proposing the use of additional personal protective equipment and restrictions on when pesticides can be applied to blooming crops in order to limit exposure to bees.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
ChatGPT-Image-Jun-24-2026-11_36_47-AM
Why the human genome is less a script than a puzzle
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
Screenshot 2026-06-25 at 10.55
Leading OB-GYN group challenges RFK, Jr. gutting of maternal vaccine schedule
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
Screenshot-2026-06-24-at-2.57.41-PM
Viewpoint: Trump’s Reflecting Pool algae fiasco points to a bigger culprit: Climate change
Screenshot-2026-06-24-at-2.40.46-PM
Hegseth reversal: As Air Force flu outbreak continues to surge, military reinstitutes mandatory vaccines for recruits
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.